Crude and relative survival rates were analyzed using data from 4,199 incident breast cancers in females and 39 breast cancers in males registered between 1974 and 1988 in the Cancer Registry of the Swiss Canton of Vaud. The relative survival rates were 0.94 for females and 0.95 for males at 1 year, 0.87 and 0.95 at 2 years, 0.71 and 0.75 at 5 years, and 0.57 and 0.65 at 10 years. In relation to age at diagnosis, among females the relative survival increased from 0.62 for cases diagnosed under the age of 35 years to 0.78 at the age of 45-49 years, decreased to 0.66-0.68 in the age group 50-59 years, and rose again to reach 0.76 at the age of 65-69 years, declining thereafter to 0.69 at the age range 80-84 years. This pattern was already evident during the first 2 years of follow-up and persisted up to 10 years after diagnosis, although somewhat less defined. For males, no significant difference was evident in relative survival between breast cancers diagnosed before or at the age of 65 years and over, and only the 10-year survival rate was apparently (though not significantly) lower at older ages. Thus, these population-based data show remarkable similarities in survival for female and male breast cancer, despite possible heterogeneities in diagnosis and ascertainment of the disease as well as differences in steroid hormone levels in the two sexes and possible differences in biological characteristics of the disease. Further, they confirm that breast cancer survival varies across subsequent age groups. This possibly reflects selection and modifying effects on incidence and survival of hormone dependency of a proportion of breast cancers, the growth of which could be accelerated during the premenopause and the survival favourably influenced by the decline in steroid hormone levels after the menopause.

Keywords:
Age, Breast cancer survival, Sex
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.